Pleno Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $25M

  • Investors
  • 5

Pleno General Information

Description

Developer of a multi-omic instrument designed for biological target detection for clinical testing and biomedical research. The company's platform provides monitoring of minimal residual disease and early multi-cancer screening, also detects a diverse collection of analytical targets that include deoxyribonucleic acid, ribonucleic acid, and protein biomarkers with unprecedented speed and precision, and leverages advanced microfluidics to automate all aspects of sample preparation and analysis, enabling healthcare providers to get access to diverse health monitoring technologies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6275 Nancy Ridge Drive
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Devices and Supplies
Corporate Office
  • 6275 Nancy Ridge Drive
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pleno Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 12-Dec-2024 $25M Completed Generating Revenue
3. Later Stage VC (Series A) 25-May-2022 Completed Generating Revenue
2. Accelerator/Incubator 01-Feb-2022 $8.55M Completed Generating Revenue
1. Seed Round $8.55M $8.55M Completed Startup
To view Pleno’s complete valuation and funding history, request access »

Pleno Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
Seed-1 8,017,517 $0.000100 $0.03 $0.32 $0.32 1x $0.32 10.99%
Seed 14,756,758 $0.000100 $0.03 $0.4 $0.4 1x $0.4 20.22%
To view Pleno’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pleno Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a multi-omic instrument designed for biological target detection for clinical testing and biomedical resear
Discovery Tools (Healthcare)
San Diego, CA
37 As of 2026

Beverly, MA
 

Broomfield, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pleno Competitors (29)

One of Pleno’s 29 competitors is Genomic Expression, a Venture Capital-Backed company based in Beverly, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomic Expression Venture Capital-Backed Beverly, MA
Flagship Biosciences Formerly VC-backed Broomfield, CO
Vizgen Venture Capital-Backed Cambridge, MA
Illumina Formerly VC-backed San Diego, CA
Harvard Bioscience Formerly PE-Backed Holliston, MA
You’re viewing 5 of 29 competitors. Get the full list »

Pleno Patents

Pleno Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026193009-A1 Cancer recurrence monitoring Pending 10-Mar-2025
WO-2026178412-A2 Identification of methylated nucleic acids Pending 21-Feb-2025
WO-2026178412-A3 Identification of methylated nucleic acids Pending 21-Feb-2025
WO-2026161646-A1 Methods and compositions for increasing detection of structural variants Pending 24-Jan-2025
WO-2026102120-A2 Instrument registration for multi-well plate Pending 07-Nov-2024 B01L3/5085
To view Pleno’s complete patent history, request access »

Pleno Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pleno Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Deerfield Management Venture Capital Minority
Foresite Capital Growth/Expansion Minority
Medical Excellence Capital Venture Capital Minority
EvoNexus Accelerator/Incubator Minority
To view Pleno’s complete investors history, request access »

Pleno FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process